The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • Ireland: Taoiseach and Minister for Health confirm introduction of PrEP programme in 2019

    Taoiseach Leo Varadkar welcomed the publication of a draft report by the Health Information and Quality Authority (HIQA) on the introduction of a pre-exposure prophylaxis (PrEP) programme aimed at preventing HIV. Health Minister Simon Harris encouraged interested parties and members of the public to give their feedback on the draft report during the consultation process which runs to 28th of May, The public consultation is at HIQA’s website: https://www.hiqa.ie/reports-and-publications/consultation/draft-hta-prep-programme

    23 April 2019 | Irish Ministry of Health
  • Hivpoint Helsinki welcomes Pre-Exposure Prophylaxis – Finnish national guidelines are here, and generic medicines hit the market soon

    The National Institute for Health and Welfare recommends PrEP for people with a high risk for HIV transmission. As a part of a comprehensive prevention program, PrEP has reduced new HIV transmissions in all countries where it is available. When used correctly, PrEP provides up to 99% reduction in HIV risk. The Finnish national guidelines are released today, 17 April 2019.

    17 April 2019 | Hivpoint
  • Pre-Exposure Prophylaxis for HIV officially launched in Hanoi

    Pre-Exposure Prophylaxis (PrEP) service for HIV prevention was officially launched in Hanoi on April 16.

    17 April 2019 | Vietnam+
  • London councils agree to take 60% new PrEP trial patients, but it might not be enough

    A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

    15 April 2019 | Gay Star News
  • More Londoners to receive HIV prevention medicine

    In a boost to HIV prevention in the capital, London boroughs have agreed to provide over 4,000 extra places on the PrEP Impact Trial. The trial – a national programme led by NHS England in partnership with Public Health England and local authorities – supplies PrEP (an HIV prevention medicine) free of charge to individuals considered to be at high risk of exposure to HIV. The expansion, which will take place over the coming weeks, represents a 60% increase in the trial places available to Londoners. London already accounts for 7,609 trial places – a higher figure than the rest of England combined.

    12 April 2019 | London Councils
  • PrEP Impact Trial Update – April 2019

    The PrEP Oversight Board met on 20 March and the main item on the agenda was to receive an update on trial site capacity and commissioner approvals of additional trial places.

    04 April 2019 | NHS England
  • Thailand: Retaining people in care key to PrEP adherence

    Study finds that younger populations under 25, transgender women, and new clients least likely to be adherent

    03 April 2019 | AVERT
  • London is facing up to reality in the HIV prevention fight

    In response to recent headlines on the PreP trial expansion, Cllr Ray Puddifoot says London boroughs are committed to playing a full part in it

    02 April 2019 | Health Service Journal
  • HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012

    HIV incidence in people who inject drugs in Bangkok declined from 5.7 per 100 person-years during the cohort study, to 2.7 per 100 person-years in the vaccine trial, to 0.7 per 100 person-years among PrEP study placebo recipients. Incidence peaked at 12.1 per 100 person-years in 1996 and declined to <1.0% during 2005–2012. Several factors likely contributed to the decline, including decreases in the frequency of injecting and sharing, improved access to HIV testing and antiretroviral therapy, and the use of PrEP. Expanding access to effective HIV prevention tools can hasten control of the HIV epidemic among PWID.

    01 April 2019 | The Lancet
  • Making the sale: Re-branding the HIV prevention pill for women

    Since the country's national rollout, less than a quarter of people who've started taking PrEP are young women — despite high HIV rates among them.

    01 April 2019 | Bhekisisa
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.